Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06844292 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Microinvasive Glaucoma Surgery: MINIject® Versus Hydrus® Microstent in Combination With Cataract Surgery

Study acronym: MINHY
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Mar 15, 2027 to Mar 3, 2027 · Completion date: Mar 15, 2031 to Mar 3, 2031 · Start date changed from estimate of Mar 15, 2025 to Mar 3, 2025 · 2 morev2 Show 5 more changesShow less
    • Primary completion date: Mar 15, 2027 to Mar 3, 2027
    • Completion date: Mar 15, 2031 to Mar 3, 2031
    • Start date changed from estimate of Mar 15, 2025 to Mar 3, 2025
    • Secondary endpoints revised (15)
    • Site details revised

    See this version in full on ClinicalTrials.gov ↗

  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study aims to investigate postoperative outcomes after two different MIGS implants (MINIject or Hydrus) in combination with cataract surgery for patients with glaucoma.
Trial Details
NCT Number NCT06844292
Lead Sponsor Medical University of Graz
Conditions Glaucoma, Cataract
Enrollment 152 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov